Replies to post #5073 on Insmed Inc (INSM)

[rod5247]

ED,

Pure HYPE! ALS is a wildcard that could hit and we may have some indications in months if this is likely but for now we are looking at years for any significant revenue. If guidance is correct, we should have enough cash to 2nd half 2008. Dr. Allan was very clear, more financing is necessary.

Could we please keep the hype and pumpers on yahoo?

Thanks and Good Luck,

Rod

[Christiaan F]

Sorry ED, ALS will not generate revenue:

"Insmed is currently supplying IPLEXTM on a cost recovery basis to these Italian patients under an Expanded Access Program. Data collected through the Expanded Access Program in Italy will be used to design future ALS clinical development studies with IPLEXTM."
http://www.insmed.com/PDF/News_Press_Release42507.pdf